Physicochemical characterization of a peptide deriving from the glycoprotein gp36 of the feline immunodeficiency virus and its lipoylated analogue in micellar systems

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 10, 2006, Pages 1653-1661

  Esposito, Cinzia ^a   D'Errico, Gerardino ^b   Armenante, Maria Rosaria ^a   Giannecchini, Simone ^d   Bendinelli, Mauro ^d   Rovero, Paolo ^c   D'Ursi, Anna M ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Conformational analysis; FIV; Lipopeptide; Micelle interface

Indexed keywords

GLYCOPROTEIN 36; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL ADHESION; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; FELINE IMMUNODEFICIENCY VIRUS; FLUORESCENCE ANALYSIS; HYDROPHOBICITY; LIPOPHILICITY; MEMBRANE STRUCTURE; MICELLE; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; STRUCTURE ANALYSIS; VIRUS MORPHOLOGY;

ANTIVIRAL AGENTS; CIRCULAR DICHROISM; DIFFUSION; ELECTRON SPIN RESONANCE SPECTROSCOPY; GLYCOPROTEINS; IMMUNODEFICIENCY VIRUS, FELINE; LIPOPROTEINS; MICELLES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHORYLCHOLINE; PROTEIN CONFORMATION; SODIUM DODECYL SULFATE; SPECTROMETRY, FLUORESCENCE; VIRAL ENVELOPE PROTEINS;

FELINE IMMUNODEFICIENCY VIRUS;

EID: 33749042125     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.06.017     Document Type: Article

References (47)

1. Pedersen N.C., Ho E.W., Brown M.L., and Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235 (1987) 790-793
2. Elder J.H., and Phillips T.R. Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. Adv. Virus Res. 45 (1995) 225-247
3. Lee T., Laco G.S., Torbett B.E., Fox H.S., Lerner D.L., Elder J.H., and Wong C.H. Analysis of the S3 and S3′ subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 939-944
4. Willett B.J., Flynn J.N., and Hosie M.J. FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today 18 (1997) 182-189
5. de Parseval A., Grant C.K., Sastry K.J., and Elder J.H. Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J. Virol. 80 (2006) 3088-3091
6. Frey S.C., Hoover E.A., and Mullins J.I. Feline immunodeficiency virus cell entry. J. Virol. 75 (2001) 5433-5440
7. Wyatt R., and Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280 (1998) 1884-1888
8. Pancino G., Camoin L., and Sonigo P. Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J. Virol. 69 (1995) 2110-2118
9. Serres P.F. Molecular mimicry between the trimeric ectodomain of the transmembrane protein of immunosuppressive lentiviruses (HIV-SIV-FIV) and interleukin 2. C. R. Acad. Sci. III 323 (2000) 1019-1029
10. Giannecchini S., Bonci F., Pistello M., Matteucci D., Sichi O., Rovero P., and Bendinelli M. The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry. Virology 320 (2004) 156-166
11. Chan D.C., and Kim P.S. HIV entry and its inhibition. Cell 93 (1998) 681-684
12. Doms R.W., and Moore J.P. HIV-1 membrane fusion: targets of opportunity. J. Cell Biol. 151 (2000) 9-14
13. Suarez T., Gallaher W.R., Agirre A., Goni F.M., and Nieva J.L. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J. Virol. 74 (2000) 8038-8047
14. Suarez T., Nir S., Goni F.M., Saez-Cirion A., and Nieva J.L. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence. FEBS Lett. 477 (2000) 145-149
15. Peisajovich S.G., Blank L., Epand R.F., Epand R.M., and Shai Y. On the interaction between gp41 and membranes: the immunodominant loop stabilizes gp41 helical hairpin conformation. J. Mol. Biol. 326 (2003) 1489-1501
16. Salzwedel K., West J.T., and Hunter E. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 73 (1999) 2469-2480
17. Schibli D.J., Montelaro R.C., and Vogel H.J. The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry 40 (2001) 9570-9578
18. Ji H., Shu W., Burling F.T., Jiang S., and Lu M. Inhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusion. J. Virol. 73 (1999) 8578-8586
19. Jin B., Jin S., Ryu R., Ahn K., and Yu Y.G. Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 16 (2000) 1797-1804
20. Judice J.K., Judice Y., Tom K., Huang W., Wrin T., Vennari J., Petropoulos C.J., and McDowell R.S. Inhibition of HIV type 1 infectivity by constrained α-helical peptides: implications for the viral fusion mechanism. Proc. Natl. Acad. Sci. USA 94 (1997) 13426-13430
21. Wild C.T., Shugars D.C., Greenwell T.K., McDanal C.B., and Matthews T.J. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9770-9774
22. Neurath A.R., Lin K., Strick N., and Jiang S. Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions. AIDS Res. Hum. Retrovir. 11 (1995) 687-696
23. Kilby J.M., Lalezari J.P., Eron J.J., Carlson M., Cohen C., Arduino R.C., Goodgame J.C., Gallant J.E., Volberding P., Murphy R.L., Valentine F., Saag M.S., Nelson E.L., Sista P.R., and Dusek A. The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res. Hum. Retrovir. 18 (2002) 685-693
24. Talbott R.L., Sparger E.E., Lovelace K.M., Fitch W.M., Pedersen N.C., Luciw P.A., and Elder J.H. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 5743-5747
25. Lombardi S., Massi C., Indino E., La Rosa C., Mazzetti P., Falcone M.L., Rovero P., Fissi A., Pieroni O., Bandecchi P., Esposito F., Tozzini F., Bendinelli M., and Garzelli C. Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides. Virology 220 (1996) 274-284
26. Giannecchini S., Di Fenza A., D'Ursi A.M., Matteucci D., Rovero P., and Bendinelli M. Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein. J. Virol. 77 (2003) 3724-3733
27. Toth I., Flinn N., Hillery A.M., Gibbons W.A., and Artursson P. Lipidic conjugates of LHRH and TRH that release and protect the native hormones in homogenates of human intestinal epithelial (Caco-2) cells. Int. J. Pharm. 105 (1994) 241-247
28. Toth I. A novel chemical approach to drug delivery: lipidamino acid conjugates. J. Drug Target. 2 (1994) 217-239
29. Toth I., Danton M., Flinn N., Hillery A.M., Wood I.P., and Gibbons W.A. A lipidic α-amino acid-based synthetic adjuvant peptide complex for increasing immunogenicity of vaccines. Biochem. Soc. Trans. 22 (1994) 1055-1058
30. Epand R.M. Biophysical studies of lipopeptide-membrane interactions. Biopolymers 43 (1997) 15-24
31. Ng K.-y., Zhao L., Meyer J.D., Rittmann-Grauer L., and Manning M.C. Use of circular dichroism spectroscopy in determining the conformation of a monoclonal antibody prior to its incorporation in an immunoliposome. J. Pharm. Biomed. Anal. 16 (1997) 507-513
32. Romano R., Musiol H.J., Weyher E., Dufresne M., and Moroder L. Peptide hormone-membrane interactions: the aggregational and conformational state of lipo-gastrin derivatives and their receptor binding affinity. Biopolymers 32 (1992) 1545-1558
33. Egelhofer M., Brandenburg G., Martinius H., Schult-Dietrich P., Melikyan G., Kunert R., Baum C., Choi I., Alexandrov A., and von Laer D. Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides. J. Virol. 78 (2004) 568-575
34. Whitmore L., and Fallace B.A. DICHROWEB, an online server for protein secondary structure analysis from circular dichroism spectroscopic data. Nucleic Acids Res. 32 (2004) 668-673
35. Tedeschi A.M., Franco L., Ruzzi M., Padano L., Corvaja C., and D'Errico G. Micellar aggregation of alkyltrimethylammonium bromide surfactants studied by electron paramagnetic resonance of an anionic nitroxide. Phys. Chem. Chem. Phys. 5 (2003) 4204-4209
36. Johnson Jr. C.S. Diffusion ordered nuclear magnetic resonance spectroscopy principles and applications. Prog. NMR Spectrosc. 34 (1999) 203-256
37. Konev S.V. Fluorescence and Phosphorescence of Proteins and Acids (1967), Plenum, New York
38. Ambrosone L., D'Errico G., and Ragone R. Interaction of tryptophan and N-acetyltryptophanamide with dodecylpentaoxyethyleneglycol ether micelles. Spectrochim. Acta 53 (1997) 1615-1620
39. Callis P.R., and Liu T. Quantitative prediction of fluorescence quantum yields for tryptophan in proteins. J. Phys. Chem., B 108 (2004) 4248-4259
40. Dufourcq J., Faucon J.F., Maget-Dana R., Pileni M.P., and Helene C. Peptide-membrane interactions. A fluorescence study of the binding of oligopeptides containing aromatic and basic residues to phospholipid vesicles. Biochim. Biophys. Acta, Biomembr. 649 (1981) 67-75
41. Santos N.C., Prieto M., and Castanho M.A. Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods. Biochim. Biophys. Acta 1612 (2003) 123-135
42. Nernst W. Verteilung eines stoffes zwishen zwei löungsmitteln und zwishen lösungsmittel und dampfraum. Z. Phys. Chem. 8 (1891) 110-139
43. Christiaens B., Symoens S., Verheyden S., Engelborghs Y., Joliot A., Prochiantz A., Vandekerckhove J., Rosseneu M., and Vanloo B. Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes. Eur. J. Biochem. 269 (2002) 2918-2926
44. Mendz G.L., Moore W.J., Kaplin I.J., Cornell B.A., Separovic F., Miller D.J., and Brown L.R. Characterization of dodecylphosphocholine/myelin basic protein complexes. Biochem. 27 (1988) 379-386
45. Kang Y.S., and Kevan L. Interaction of Poly(ethylene oxide) with sodium dodecyl sulfate micelle interface studied with nitroxide spin probes. J. Phys. Chem. 98 (1994) 7624-7627
46. Kallick D.A., Tessmer M.R., Watts C.R., and Li C.Y. The use of dodecylphosphocholine micelles in solution NMR. J. Magn. Reson., Ser. B 109 (1995) 60-65
47. Albrizio S., Caliendo G., D'Errico G., Novellino E., Rovero P., and D'Ursi A.M. Galphas protein C-terminal alpha-helix at the interface: does the plasma membrane play a critical role in the Galphas protein functionality. J. Pept. Sci. 11 (2005) 617-626